Congress ticker disclosure profile

As of July 3 at 11:44 PM EDT

Public STOCK Act rows mentioning

SGSOY

A factual page for public Congressional disclosures that reference SGSOY. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.

90d rows

0

Feed lifetime

16

Member filers

6

Disclosed ranges

Amount not disclosed

Latest source-stamped receipts

Latest trade Jul 10, 2023

DateMemberActionAmountFiledReceipt
Jul 10, 2023Daniel GoldmanSellAmount not disclosedDate not disclosedOpen card
Mar 31, 2023Daniel GoldmanSellAmount not disclosedDate not disclosedOpen card
Aug 2, 2022Josh GottheimerSellAmount not disclosedDate not disclosedOpen card
Feb 17, 2021Peter MeijerSellAmount not disclosedDate not disclosedOpen card
Jan 28, 2021Peter MeijerSellAmount not disclosedDate not disclosedOpen card
Aug 4, 2020Greg GianforteSellAmount not disclosedDate not disclosedOpen card
Jan 13, 2020Greg GianforteBuyAmount not disclosedDate not disclosedOpen card
Oct 11, 2019Greg GianforteBuyAmount not disclosedDate not disclosedOpen card
Sep 10, 2019Greg GianforteSellAmount not disclosedDate not disclosedOpen card
Jun 24, 2019Donna ShalalaSellAmount not disclosedDate not disclosedOpen card
Apr 10, 2019Greg GianforteBuyAmount not disclosedDate not disclosedOpen card
Apr 8, 2019Donna ShalalaBuyAmount not disclosedDate not disclosedOpen card
Apr 8, 2019Josh GottheimerBuyAmount not disclosedDate not disclosedOpen card
Apr 5, 2019Donna ShalalaBuyAmount not disclosedDate not disclosedOpen card
Apr 5, 2019Josh GottheimerBuyAmount not disclosedDate not disclosedOpen card
Jan 27, 2015Thomas MacarthurSellAmount not disclosedDate not disclosedOpen card

Source creed

This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 0 of 16 filed rows include disclosed amount ranges (0.0%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.

Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.